These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35398586)

  • 1. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
    Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
    Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
    Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
    Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging.
    Ding Y; Huang Z; Luo Y; Lin H; Wang J; Zeng Z; Zhang T; Chen Y; Gong Y; Zhang M; Zhao C
    Acta Biomater; 2024 Oct; 187():316-327. PubMed ID: 39151666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
    Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
    Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
    Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
    Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species-activatable self-amplifying Watson-Crick base pairing-inspired supramolecular nanoprodrug for tumor-specific therapy.
    Xu X; Zeng Z; Ding X; Shan T; Liu Q; Chen M; Chen J; Xia M; He Y; Huang Z; Huang Y; Zhao C
    Biomaterials; 2021 Oct; 277():121128. PubMed ID: 34537502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binary dimeric prodrug nanoparticles for self-boosted drug release and synergistic chemo-photodynamic therapy.
    Zhang Y; Pei Q; Yue Y; Xie Z
    J Mater Chem B; 2022 Feb; 10(6):880-886. PubMed ID: 35043826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
    Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
    ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy.
    Zhu R; He Q; Li Z; Ren Y; Liao Y; Zhang Z; Dai Q; Wan C; Long S; Kong L; Fan W; Yu W
    Acta Biomater; 2022 Nov; 153():442-452. PubMed ID: 36179978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broaden sources and reduce expenditure: Tumor-specific transformable oxidative stress nanoamplifier enabling economized photodynamic therapy for reinforced oxidation therapy.
    Xu X; Huang B; Zeng Z; Chen J; Huang Z; Guan Z; Chen M; Huang Y; Zhao C
    Theranostics; 2020; 10(23):10513-10530. PubMed ID: 32929363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
    Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
    ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextran-based micelles for combinational chemo-photodynamic therapy of tumors via in vivo chemiluminescence.
    Ding C; Shi Z; Ou M; Li Y; Huang L; Wang W; Huang Q; Li M; Chen C; Zeng X; Chen H; Mei L
    Carbohydr Polym; 2023 Nov; 319():121192. PubMed ID: 37567697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
    Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
    Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Dual-Responsive Prodrug-MOFs as Immunogenic Cell Death Initiator for Enhancing Cancer Immunotherapy.
    Hu X; Li R; Liu J; Fang K; Dong C; Shi S
    Adv Healthc Mater; 2024 Mar; 13(7):e2302333. PubMed ID: 38253350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained By Employing a Nano-MOF with Cu
    Zhang W; Lu J; Gao X; Li P; Zhang W; Ma Y; Wang H; Tang B
    Angew Chem Int Ed Engl; 2018 Apr; 57(18):4891-4896. PubMed ID: 29451722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-level Reactive Oxygen Species Amplifier to Enhance Photo-/Chemo-Dynamic/Ca
    Yu H; Xu G; Wen C; Yu B; Jin Y; Yin XB
    ACS Appl Mater Interfaces; 2024 Apr; 16(15):18459-18473. PubMed ID: 38578815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.